342 related articles for article (PubMed ID: 16924046)
1. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
[TBL] [Abstract][Full Text] [Related]
2. Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer.
Iyer S; Friedli A; Bowes L; Kricorian G; Fitzpatrick RE
Lasers Surg Med; 2004; 34(2):114-9. PubMed ID: 15004822
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
4. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
5. High sun protection factor sunscreens in the suppression of actinic neoplasia.
Naylor MF; Boyd A; Smith DW; Cameron GS; Hubbard D; Neldner KH
Arch Dermatol; 1995 Feb; 131(2):170-5. PubMed ID: 7857113
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment.
Jury CS; Ramraka-Jones VS; Gudi V; Herd RM
Br J Dermatol; 2005 Oct; 153(4):808-10. PubMed ID: 16181465
[TBL] [Abstract][Full Text] [Related]
7. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
[TBL] [Abstract][Full Text] [Related]
8. A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses.
Ostertag JU; Quaedvlieg PJ; van der Geer S; Nelemans P; Christianen ME; Neumann MH; Krekels GA
Lasers Surg Med; 2006 Sep; 38(8):731-9. PubMed ID: 16912977
[TBL] [Abstract][Full Text] [Related]
9. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Levine N; Grogan T
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):343-8. PubMed ID: 9162299
[TBL] [Abstract][Full Text] [Related]
11. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Stockfleth E; Kerl H; Zwingers T; Willers C
Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
[TBL] [Abstract][Full Text] [Related]
12. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study.
Apalla Z; Sotiriou E; Chovarda E; Lefaki I; Devliotou-Panagiotidou D; Ioannides D
Br J Dermatol; 2010 Jan; 162(1):171-5. PubMed ID: 19863513
[TBL] [Abstract][Full Text] [Related]
13. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial.
Weinstock MA; Bingham SF; Cole GW; Eilers D; Naylor MF; Kalivas J; Taylor JR; Gladstone HB; Piacquadio DJ; DiGiovanna JJ
Arch Dermatol; 2001 Aug; 137(8):1055-8. PubMed ID: 11493098
[TBL] [Abstract][Full Text] [Related]
14. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study.
Jorizzo J; Weiss J; Vamvakias G
J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881
[TBL] [Abstract][Full Text] [Related]
15. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
[TBL] [Abstract][Full Text] [Related]
16. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
17. Laser-mediated photodynamic therapy of actinic keratoses.
Alexiades-Armenakas MR; Geronemus RG
Arch Dermatol; 2003 Oct; 139(10):1313-20. PubMed ID: 14568836
[TBL] [Abstract][Full Text] [Related]
18. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
[TBL] [Abstract][Full Text] [Related]
20. Clinical recognition of actinic keratoses in a high-risk population: how good are we?
Venna SS; Lee D; Stadecker MJ; Rogers GS
Arch Dermatol; 2005 Apr; 141(4):507-9. PubMed ID: 15837871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
